Skip to main content
    U

    Universal Health Services Inc (UHS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $197.81
    +3.74 (+1.92%)

    Market Cap: $11.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Universal Health Services Inc (UHS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Universal Health Services (UHS) to earn $22.44 per share in the fiscal year ending Dec 31, 2026, on revenue of $18.61B. Of 20 analysts, 6 rate the stock Buy or Strong Buy, 13 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 10 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 20 ratings average 2.80, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy630.0%
    Hold1365.0%
    Sell00.0%
    Strong Sell15.0%
    Consensus
    Hold
    Total analysts
    20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 2.1% and revenue estimates rise 4.7%.

    Fiscal year ending Dec 31, 2026
    $22.44
    EPS consensus, revenue $18.61B
    Fiscal year ending Dec 31, 2027
    $22.92
    EPS consensus, revenue $19.49B
    Next report
    Feb 23, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$22.44$21.76 to $22.7313$18.61B$18.51B to $18.71B18
    Dec 31, 2027$22.92$21.06 to $24.3015$19.49B$19.05B to $19.82B17

    Quarterly Estimates

    The EPS consensus falls from $5.66 for the quarter ending Dec 31, 2026 to $5.62 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$5.66$4.80 to $6.1719$4.79B$4.55B to $5.09B17
    Mar 31, 2027$5.62$4.87 to $6.419$4.74B$4.63B to $4.81B9

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 26 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026210
    Fiscal year ending Dec 31, 202719
    Quarter ending Mar 31, 202707

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 0.5% from $22.56.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$22.44$22.48$22.59$22.52$22.56-0.5%
    Fiscal year ending Dec 31, 2027$22.92$22.99$23.96$24.02$24.16-5.1%
    Quarter ending Mar 31, 2027$5.62$5.60$5.92$6.00$6.02-6.6%

    Frequently Asked Questions About UHS

    What is the UHS stock forecast?

    Consensus analyst estimates put Universal Health Services's EPS at $22.44 for the fiscal year ending Dec 31, 2026, on revenue of $18.61B. The consensus rating from 20 analysts is Hold.

    How do analysts rate UHS stock?

    Of 20 analysts covering Universal Health Services, 0 rate it Strong Buy, 6 Buy, 13 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from UHS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $22.44, with estimates from $21.76 to $22.73 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $22.92, with estimates from $21.06 to $24.30 from 15 analysts.

    What revenue do analysts expect from Universal Health Services next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $18.61B, with estimates from $18.51B to $18.71B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $19.49B, with estimates from $19.05B to $19.82B.

    How many analysts cover UHS?

    20 analysts rate Universal Health Services stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.